Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -5.53% vs 34.90% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 43.64% vs -109.01% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 12.01% vs -6,260.00% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 260.00% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Guangdong Hybribio Biotech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -5.53% vs 34.90% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -15.14% vs -17.46% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 43.64% vs -109.01% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 80.73% vs -1,094.14% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 12.01% vs -6,260.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 81.30% vs -712.68% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 260.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 260.00% vs -64.29% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






